Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Clarke

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
BMJ Open|August 8, 2018
The HARMONIC trial: study protocol for a randomised controlled feasibility trial of Shaping Healthy Minds-a modular transdiagnostic intervention for mood, stressor-related and anxiety disorders in adultsMelissa Black, Caitlin Hitchcock, Anna Bevan, et al.
Cell Stem Cell|April 8, 2021
Human naive epiblast cells possess unrestricted lineage potentialGe Guo, Giuliano Giuseppe Stirparo, Stanley E Strawbridge, et al.
Plos One|October 9, 2024
The RETurn to work After stroKE (RETAKE) trial: Findings from a mixed-methods process evaluation of the Early Stroke Specialist Vocational Rehabilitation (ESSVR) interventionDavid James Clarke, Katie Powers, Diane Trusson, et al.
The Journal of Chemical Physics|August 21, 2024
Morphological control of bundled actin networks subject to fixed-mass depletionJames Clarke, Lauren Melcher, Anne D Crowell, et al.
Stem Cell Reports|November 12, 2019
Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive PluripotencyNicholas Bredenkamp, Jian Yang, James Clarke, et al.
RSC Advances|February 21, 2024
Development of a selective and scalable <i>N</i>1-indazole alkylationJimmy Wang, Aaron Mccreanney, Amelia Taylor-Young, et al.
The Journal of Endocrinology|May 18, 2026
Triiodothyronine-driven pro-inflammatory responses of dendritic cells are restrained by sphingolipid signalingDana María Negretti-Borga, Mariana Pires Teixeira, Antonella Blanco, et al.
British Journal of Cancer|May 26, 2023
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumorsAnthony B El-Khoueiry, James Clarke, Tobias Neff, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Nature Immunology|June 25, 2021
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacySimon Eschweiler, James Clarke, Ciro Ramírez-Suástegui, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
BMJ Open|August 8, 2018
The HARMONIC trial: study protocol for a randomised controlled feasibility trial of Shaping Healthy Minds-a modular transdiagnostic intervention for mood, stressor-related and anxiety disorders in adultsMelissa Black, Caitlin Hitchcock, Anna Bevan, et al.
Cell Stem Cell|April 8, 2021
Human naive epiblast cells possess unrestricted lineage potentialGe Guo, Giuliano Giuseppe Stirparo, Stanley E Strawbridge, et al.
Plos One|October 9, 2024
The RETurn to work After stroKE (RETAKE) trial: Findings from a mixed-methods process evaluation of the Early Stroke Specialist Vocational Rehabilitation (ESSVR) interventionDavid James Clarke, Katie Powers, Diane Trusson, et al.
The Journal of Chemical Physics|August 21, 2024
Morphological control of bundled actin networks subject to fixed-mass depletionJames Clarke, Lauren Melcher, Anne D Crowell, et al.
Stem Cell Reports|November 12, 2019
Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive PluripotencyNicholas Bredenkamp, Jian Yang, James Clarke, et al.
RSC Advances|February 21, 2024
Development of a selective and scalable <i>N</i>1-indazole alkylationJimmy Wang, Aaron Mccreanney, Amelia Taylor-Young, et al.
The Journal of Endocrinology|May 18, 2026
Triiodothyronine-driven pro-inflammatory responses of dendritic cells are restrained by sphingolipid signalingDana María Negretti-Borga, Mariana Pires Teixeira, Antonella Blanco, et al.
British Journal of Cancer|May 26, 2023
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumorsAnthony B El-Khoueiry, James Clarke, Tobias Neff, et al.
The Journal of Experimental Medicine|June 10, 2020
BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppressionFrancis M Grant, Jie Yang, Rabab Nasrallah, et al.
Nature Immunology|June 25, 2021
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacySimon Eschweiler, James Clarke, Ciro Ramírez-Suástegui, et al.
Pageof 10